A comparison of prostate cancer detection rates by 12 or 6 core biopsy at different prostate-specific antigen densities in Korean men.
OBJECTIVE
To evaluate the diagnostic value of 12 core biopsy versus sextant biopsy at different prostatic-specific antigen densities (PSAD).


METHODS
We retrospectively analyzed the records of 1,463 patients who underwent transrectal ultrasound-guided prostate biopsies at our institution. 995 patients underwent 12 core biopsy and 468 sextant biopsy of the prostate. The cancer detection rates achieved by these two methods were analyzed at different PSAD levels.


RESULTS
All patients were stratified into 5 groups according to PSAD level; group A: PSAD < 0.1 (n = 290), group B: 0.1 < or = PSAD < 0.2 (n = 572), group C: 0.2 < or = PSAD < 0.3 (n = 248), group D: 0.3 < or = PSAD < 0.4 (n = 122), and group E: PSAD > or = 0.4 (n = 231). In group B, 12 core biopsy had a higher detection rate than 6 core biopsy (P = 0.017).


CONCLUSIONS
These results demonstrate 12 core biopsy is better able to detect cancer than 6 core biopsy in patients with a PSAD in the range 0.1-0.2, which suggests that PSAD be considered when deciding on the number of prostate biopsy cores required.
Jeong
Hyeon
H
Department of Urology, Seoul Municipal Boramae Hospital, Seoul, Korea.
Jeong
Byong Chang
BC
Kwak
Cheol
C
Lee
Eunsik
E
Lee
Sang Eun
SE
Kim
Tae Beom
TB
D000368:Aged; D044466:Asian People / Q000706:statistics & numerical data; D001706:Biopsy / Q000379:methods* / Q000592:standards*; D006801:Humans; D007723:Korea / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000208:ethnology / Q000473:pathology*; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012307:Risk Factors
D017430:Prostate-Specific Antigen